AKBA News and Press, Akebia Therapeutics Inc. From 03/28/24

A look at the top 10 most actives in the United States Akanda Corp. (AKAN) rose 54.8% to $0.2552 on volume of 35,107,796 shares Nikola Corporation (NKLA) rose 5.0% to $0.9546 on volume of 25,515,019 shares Biodexa Pharmaceuticals plc (BDRX) rose 83.9% to $1.58 on volume of 24,185,655 shar...

2024-03-28 09:20:29 ET DENVER, Colo., Mar 28, 2024 ( 247marketnews.com )- This morning’s notable listings with recent news include Treasure & Shipwreck Recovery (OTCPK: BLIS ), Akebia Therapeutics, Inc. (NASDAQ: AKBA ), Avalo Therapeutics, Inc. (NASDAQ: AV...

2024-03-28 07:21:49 ET DENVER, Colo., Mar 28, 2024 ( 247marketnews.com )- Akebia Therapeutics, Inc. (NASDAQ: AKBA ) announced, last night, that the U.S. Food and Drug Administration approved Vafseo (vadadustat) Tablets, which is now approved in 37 countries, for the treatment of ane...

2024-03-28 05:42:57 ET Akebia Therapeutics ( NASDAQ: AKBA ) shares surged over 25% premarket on Thursday after the U.S. Food and Drug Administration (FDA) approved its Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adult patients o...

2024-03-28 05:41:26 ET More on related stocks RH (RH) Q4 2023 Earnings Call Transcript RH: Q4 Earnings, Improved Results May Be Coming, But Are Likely Priced In MillerKnoll, Inc. (MLKN) Q3 2024 Earnings Call Transcript Intuitive Machines files to sell $300M c...

2024-03-22 15:00:00 ET More on the markets Wall Street Lunch: Fed Not Spooked By Recent Inflation SPY: Don't Fall For The Greed SPY: Assessing Economic Risks And Market Trends (Technical Analysis, Rating Downgrade) Investors sell $66B worth of money market fu...

2024-03-14 17:17:53 ET More on Akebia Akebia Therapeutics closes up to $55M loan facility Seeking Alpha’s Quant Rating on Akebia Historical earnings data for Akebia Financial information for Akebia Read the full article on Seeking Alpha ...

Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights PR Newswire Potential vadadustat U.S. approval on PDUFA date of March 27, 2024 Strengthened balance sheet with $55.0 million term loan financing a...

AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...

Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results PR Newswire CAMBRIDGE, Mass. , March 11, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to b...